Clinical Research Directory
Browse clinical research sites, groups, and studies.
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Sponsor: Aura Biosciences
Summary
The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.
Official title: A Phase 2, Open-Label, Dose Escalation Trial Assessing the Safety, Tolerability, and Treatment Effect of Belzupacap Sarotalocan (AU-011) With Suprachoroidal Administration in Subjects With Metastases to the Choroid
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2024-12-16
Completion Date
2027-10-31
Last Updated
2026-03-13
Healthy Volunteers
No
Conditions
Interventions
AU-011
AU-011 Via Suprachoroidal Administration with laser treatment
SCS Microinjector
Suprachoroidal Injection Device
Laser
Laser Administration
Locations (10)
Byers Eye Institute at Stanford University
Palo Alto, California, United States
Bascom Palmer Eye Institute
Miami, Florida, United States
Massachusetts Eye and Ear
Boston, Massachusetts, United States
Kellogg Eye Center
Ann Arbor, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
Cleveland Clinic, Cole Eye Institute
Cleveland, Ohio, United States
Shields and Shields, PC
Philadelphia, Pennsylvania, United States
Tennessee Retina, PC
Nashville, Tennessee, United States
Retina Consultants of Texas
Bellaire, Texas, United States
University of Washington
Seattle, Washington, United States